WavoDyne Therapeutics' Grant

WavoDyne Therapeutics raised a round of funding on August 29, 2014. Investors include National Institutes of Health.

WavoDyne Therapeutics was formed for the purpose of commercializing a group of novel small molecule therapeutics which have displayed exceptional potency in preclinical models for the treatment of mem…

Articles about WavoDyne Therapeutics' Grant: